Copyright Reports & Markets. All rights reserved.

Global Biopolar Disorder Therapeutics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Biopolar Disorder Therapeutics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Biopolar Disorder Therapeutics Market Size Growth Rate by Product
      • 1.4.2 Mood Stabilizers
      • 1.4.3 Antipsychotic Drugs
      • 1.4.4 Antidepressant Drugs
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Biopolar Disorder Therapeutics Market Size Growth Rate by End User
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Biopolar Disorder Therapeutics Market Size
      • 2.1.1 Global Biopolar Disorder Therapeutics Revenue 2014-2025
      • 2.1.2 Global Biopolar Disorder Therapeutics Sales 2014-2025
    • 2.2 Biopolar Disorder Therapeutics Growth Rate by Regions
      • 2.2.1 Global Biopolar Disorder Therapeutics Sales by Regions
      • 2.2.2 Global Biopolar Disorder Therapeutics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Biopolar Disorder Therapeutics Sales by Manufacturers
      • 3.1.1 Biopolar Disorder Therapeutics Sales by Manufacturers
      • 3.1.2 Biopolar Disorder Therapeutics Sales Market Share by Manufacturers
      • 3.1.3 Global Biopolar Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Biopolar Disorder Therapeutics Revenue by Manufacturers
      • 3.2.1 Biopolar Disorder Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Biopolar Disorder Therapeutics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Biopolar Disorder Therapeutics Price by Manufacturers
    • 3.4 Biopolar Disorder Therapeutics Manufacturing Base Distribution, Product Types
      • 3.4.1 Biopolar Disorder Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Biopolar Disorder Therapeutics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Biopolar Disorder Therapeutics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Biopolar Disorder Therapeutics Sales by Product
    • 4.2 Global Biopolar Disorder Therapeutics Revenue by Product
    • 4.3 Biopolar Disorder Therapeutics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Biopolar Disorder Therapeutics Breakdown Data by End User

    6 North America

    • 6.1 North America Biopolar Disorder Therapeutics by Countries
      • 6.1.1 North America Biopolar Disorder Therapeutics Sales by Countries
      • 6.1.2 North America Biopolar Disorder Therapeutics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Biopolar Disorder Therapeutics by Product
    • 6.3 North America Biopolar Disorder Therapeutics by End User

    7 Europe

    • 7.1 Europe Biopolar Disorder Therapeutics by Countries
      • 7.1.1 Europe Biopolar Disorder Therapeutics Sales by Countries
      • 7.1.2 Europe Biopolar Disorder Therapeutics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Biopolar Disorder Therapeutics by Product
    • 7.3 Europe Biopolar Disorder Therapeutics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Biopolar Disorder Therapeutics by Countries
      • 8.1.1 Asia Pacific Biopolar Disorder Therapeutics Sales by Countries
      • 8.1.2 Asia Pacific Biopolar Disorder Therapeutics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Biopolar Disorder Therapeutics by Product
    • 8.3 Asia Pacific Biopolar Disorder Therapeutics by End User

    9 Central & South America

    • 9.1 Central & South America Biopolar Disorder Therapeutics by Countries
      • 9.1.1 Central & South America Biopolar Disorder Therapeutics Sales by Countries
      • 9.1.2 Central & South America Biopolar Disorder Therapeutics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Biopolar Disorder Therapeutics by Product
    • 9.3 Central & South America Biopolar Disorder Therapeutics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Biopolar Disorder Therapeutics by Countries
      • 10.1.1 Middle East and Africa Biopolar Disorder Therapeutics Sales by Countries
      • 10.1.2 Middle East and Africa Biopolar Disorder Therapeutics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Biopolar Disorder Therapeutics by Product
    • 10.3 Middle East and Africa Biopolar Disorder Therapeutics by End User

    11 Company Profiles

    • 11.1 Allergan
      • 11.1.1 Allergan Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Allergan Biopolar Disorder Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Allergan Biopolar Disorder Therapeutics Products Offered
      • 11.1.5 Allergan Recent Development
    • 11.2 AstraZeneca
      • 11.2.1 AstraZeneca Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 AstraZeneca Biopolar Disorder Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 AstraZeneca Biopolar Disorder Therapeutics Products Offered
      • 11.2.5 AstraZeneca Recent Development
    • 11.3 Eli Lilly
      • 11.3.1 Eli Lilly Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Eli Lilly Biopolar Disorder Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Eli Lilly Biopolar Disorder Therapeutics Products Offered
      • 11.3.5 Eli Lilly Recent Development
    • 11.4 GlaxoSmithKline
      • 11.4.1 GlaxoSmithKline Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 GlaxoSmithKline Biopolar Disorder Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 GlaxoSmithKline Biopolar Disorder Therapeutics Products Offered
      • 11.4.5 GlaxoSmithKline Recent Development
    • 11.5 Janssen Pharmaceuticals
      • 11.5.1 Janssen Pharmaceuticals Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Janssen Pharmaceuticals Biopolar Disorder Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Janssen Pharmaceuticals Biopolar Disorder Therapeutics Products Offered
      • 11.5.5 Janssen Pharmaceuticals Recent Development

    12 Future Forecast

    • 12.1 Biopolar Disorder Therapeutics Market Forecast by Regions
      • 12.1.1 Global Biopolar Disorder Therapeutics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Biopolar Disorder Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.2 Biopolar Disorder Therapeutics Market Forecast by Product
      • 12.2.1 Global Biopolar Disorder Therapeutics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Biopolar Disorder Therapeutics Revenue Forecast by Product 2019-2025
    • 12.3 Biopolar Disorder Therapeutics Market Forecast by End User
    • 12.4 North America Biopolar Disorder Therapeutics Forecast
    • 12.5 Europe Biopolar Disorder Therapeutics Forecast
    • 12.6 Asia Pacific Biopolar Disorder Therapeutics Forecast
    • 12.7 Central & South America Biopolar Disorder Therapeutics Forecast
    • 12.8 Middle East and Africa Biopolar Disorder Therapeutics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Biopolar Disorder Therapeutics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics.
      Rise in prevalence of bipolar disorder, high unmet medical needs, technological advancement and government initiatives are the key factors accelerating the growth of the bipolar disorder therapeutics market. Increase in investment in research and development and collaboration activities between companies for product development are the other factors likely to propel the bipolar disorder therapeutics market. Additionally, the rise in awareness about the disorder has led to increased understanding among the public. This has led to a rise in the number of individuals seeking medical attention for the treatment of the disorder. Also, strategic alliances formed between vendors help in increased penetration of the drugs in the market and increase market share. However, stringent regulations act as a major restraint of the bipolar disorder therapeutics market. North America dominates the global bipolar disorder therapeutics market due to new product innovation, increased awareness among people about bipolar disease, and rise in prevalence of bipolar disorders.
      The global Biopolar Disorder Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biopolar Disorder Therapeutics market based on company, product type, end user and key regions.

      This report studies the global market size of Biopolar Disorder Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biopolar Disorder Therapeutics in these regions.
      This research report categorizes the global Biopolar Disorder Therapeutics market by top players/brands, region, type and end user. This report also studies the global Biopolar Disorder Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Allergan
      AstraZeneca
      Eli Lilly
      GlaxoSmithKline
      Janssen Pharmaceuticals

      Market size by Product
      Mood Stabilizers
      Antipsychotic Drugs
      Antidepressant Drugs
      Others
      Market size by End User
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Biopolar Disorder Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Biopolar Disorder Therapeutics market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Biopolar Disorder Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Biopolar Disorder Therapeutics submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Biopolar Disorder Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biopolar Disorder Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now